Trials / Completed
CompletedNCT00829816
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Medivation, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dimebon | |
| DRUG | Placebo |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-04-01
- Completion
- 2010-08-01
- First posted
- 2009-01-27
- Last updated
- 2015-11-10
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00829816. Inclusion in this directory is not an endorsement.